Ticker >

Vaidya Sane Ayur Lab share price

Vaidya Sane Ayurved Laboratories Ltd.

NSE: MADHAVBAUG SECTOR: Hospital & Healthcare Services  15k   4   1

155.75
+3.75 (2.47%)
NSE: 14 Jun 03:56 PM

Price Summary

Today's High

₹ 155.75

Today's Low

₹ 150

52 Week High

₹ 376.95

52 Week Low

₹ 145

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

163.75 Cr.

Enterprise Value

162.13 Cr.

No. of Shares

1.05 Cr.

P/E

156.55

P/B

4.01

Face Value

₹ 10

Div. Yield

0.16 %

Book Value (TTM)

₹  38.82

CASH

1.75 Cr.

DEBT

0.13 Cr.

Promoter Holding

66.34 %

EPS (TTM)

₹  0.99

Sales Growth

32.55%

ROE

13.53 %

ROCE

19.94%

Profit Growth

49.61 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year32.55%
3 Year9.59%
5 YearNA

Profit Growth

1 Year49.61%
3 Year124.5%
5 YearNA

ROE%

1 Year13.53%
3 Year11.03%
5 Year6.44%

ROCE %

1 Year19.94%
3 Year16.72%
5 Year12.79%

Debt/Equity

0.0033

Price to Cash Flow

-381.43

Interest Cover Ratio

9.0842302292934

CFO/PAT (5 Yr. Avg.)

0.147502141339533

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 66.34 0
Dec 2023 66.34 0
Sep 2023 66.34 0
Jun 2023 66.34 0
Mar 2023 66.34 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.9293 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 9.0842302292934.
  • The company has an efficient Cash Conversion Cycle of -80.4145790323646 days.
  • Company has a healthy liquidity position with current ratio of 2.239444936522.
  • The company has a high promoter holding of 66.34%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.71866497282153.

 Limitations

  • The company has shown a poor revenue growth of 9.5933994652391% for the Past 3 years.
  • Company has negative cash flow from operations of -0.4293.
  • The company is trading at a high PE of 156.55.
  • The company is trading at a high EV/EBITDA of 34.2986.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 62.5 75.23 52.27 74.71 99.03
Total Expenditure 59.4 72.32 48.97 67.39 90.03
Operating Profit 3.1 2.91 3.3 7.32 9
Other Income 0.07 0.07 0.1 0.34 1.36
Interest 0.7 1.2 0.51 0.63 0.85
Depreciation 1.59 2.23 2.45 2.29 2.6
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.88 -0.45 0.45 4.75 6.91
Tax 0.39 0.11 0.06 1.28 1.72
Net Profit 0.5 -0.56 0.39 3.47 5.19
Adjusted EPS (Rs.) 0 0 0.56 3.3 4.94

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.05 0.05 0.05 10.51 10.51
Total Reserves 8.74 8.17 9.72 25.37 30.3
Borrowings 0 0 0 0 0
Other N/C liabilities 1.07 2.14 2.08 1.61 1.6
Current liabilities 19.03 18.75 13.92 12.51 12.87
Total Liabilities 28.88 29.11 25.76 50.01 55.28
Assets
Net Block 15.66 15.51 17.16 17.01 20.95
Capital WIP 2.02 3.79 0.38 1.23 1.67
Intangible WIP 0 0 0 0 0
Investments 0.02 0.02 0.01 4.88 1.05
Loans & Advances 1.14 1.29 1.03 1.41 2.78
Other N/C Assets 0 0 0 0 0
Current Assets 10.04 8.5 7.19 25.48 28.82
Total Assets 28.88 29.11 25.76 50.01 55.28
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.88 -0.45 1.61 4.75 6.91
Adjustment 2.09 3.09 1.59 2.15 1.43
Changes in Assets & Liabilities -0.96 5.27 3.18 -19.02 -6.14
Tax Paid -0.43 -0.19 -0.62 -1.19 -2.62
Operating Cash Flow 1.58 7.72 5.77 -13.31 -0.43
Investing Cash Flow -10.05 -3.93 -0.67 -7.52 1
Financing Cash Flow 7.71 -3.63 -5.26 22.49 -1.38
Net Cash Flow -0.76 0.16 -0.16 1.66 -0.81

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 66.34 66.34 66.34 66.34 66.34
rekha jitesh paralkar 0.05 0.05 0.05 0.05 0.05
rohit madhav sane 66.29 66.29 - 66.29 66.29
dr. rohit madhav sane - - 66.29 - -
PARTICULARS Sep 2022% Dec 2022% Mar 2023%
investors 33.66 33.66 33.66
dharmesh c patel - 3.97 3.97
santosh kudva - - 1.76
vinayak kudva - - 2.23
virtuous capital limited - - 4.98
virtuous capital limited... 5.01 4.98 -
bhh securities private li... - 1.52 -
santosh gopalkrishna kudv... - 1.76 -
sharad beharilal harlalka... - 1.10 -
vinayak gopalkrishna kudv... - 2.85 -
bhh securities private l... 1.52 - -
dharmesh c patel 3.97 - -
santosh gopalkrishna kud... 1.76 - -
sharad beharilal harlalk... 1.10 - -
vinayak gopalkrishna kud... 2.85 - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

 No Latest News available for this company.
Report us

Vaidya Sane Ayur Lab Stock Price Analysis and Quick Research Report. Is Vaidya Sane Ayur Lab an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Vaidya Sane Ayur Lab and its performance over the period of time. Vaidya Sane Ayur Lab stock price today is Rs 155.75.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Vaidya Sane Ayur Lab cash from the operating activity was Rs -0.4293 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Vaidya Sane Ayur Lab has a Debt to Equity ratio of 0.0033 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Vaidya Sane Ayur Lab , the EPS growth was 49.6090435204267 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Vaidya Sane Ayur Lab has OPM of 9.08746644800224 % which is a bad sign for profitability.
     
  • ROE: Vaidya Sane Ayur Lab have a average ROE of 13.5345875210582 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Vaidya Sane Ayur Lab is Rs 155.75. One can use valuation calculators of ticker to know if Vaidya Sane Ayur Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Vaidya Sane Ayur Lab
X